CN114533646A - 一种依克多因抗皱修护保湿精华及制备方法 - Google Patents
一种依克多因抗皱修护保湿精华及制备方法 Download PDFInfo
- Publication number
- CN114533646A CN114533646A CN202210219964.XA CN202210219964A CN114533646A CN 114533646 A CN114533646 A CN 114533646A CN 202210219964 A CN202210219964 A CN 202210219964A CN 114533646 A CN114533646 A CN 114533646A
- Authority
- CN
- China
- Prior art keywords
- composition
- component
- wrinkle
- percent
- moisturizing essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 36
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 30
- 230000008439 repair process Effects 0.000 title claims abstract description 19
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 52
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920001184 polypeptide Polymers 0.000 claims abstract description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 16
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 12
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 12
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 8
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 8
- 229920002527 Glycogen Polymers 0.000 claims abstract description 8
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960000458 allantoin Drugs 0.000 claims abstract description 8
- 229960001631 carbomer Drugs 0.000 claims abstract description 8
- 229940096919 glycogen Drugs 0.000 claims abstract description 8
- 241000620196 Arthrospira maxima Species 0.000 claims abstract description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 16
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 16
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 7
- 241000028204 Vincetoxicum atratum Species 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000011265 semifinished product Substances 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 5
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims description 4
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 4
- LODWEXDBRZBADB-XEVVZDEMSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-methylbutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O LODWEXDBRZBADB-XEVVZDEMSA-N 0.000 claims description 4
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 4
- YDSVPIYLRFZLAT-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N Chemical compound C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N YDSVPIYLRFZLAT-UHFFFAOYSA-N 0.000 claims description 4
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 4
- 108010087806 Carnosine Proteins 0.000 claims description 4
- 108010016626 Dipeptides Proteins 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 4
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims description 4
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 229940044199 carnosine Drugs 0.000 claims description 4
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 4
- 229920006037 cross link polymer Polymers 0.000 claims description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 4
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 claims description 4
- 229940094912 palmitoyl tripeptide-5 Drugs 0.000 claims description 4
- -1 tridecapeptide-1 Chemical compound 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 235000003724 spirulina extract Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 230000006750 UV protection Effects 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 230000032677 cell aging Effects 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000008591 skin barrier function Effects 0.000 abstract description 4
- 230000037380 skin damage Effects 0.000 abstract description 4
- 230000037067 skin hydration Effects 0.000 abstract description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 4
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种依克多因抗皱修护保湿精华及制备方法，其技术方案要点是：依克多因抗皱修护保湿精华，包括以下质量百分比组分：水77.3％；甘油5％；1,3‑丙二醇5％；多肽组合物5％；极大螺旋藻提取物2％；1,2‑戊二醇2％；滋养组合物2％；抑菌组合物0.6％；保湿组合物0.5％；糖原0.2％；尿囊素0.2％；卡波姆0.15％；三乙醇胺0.15％；EDTA二钠0.05％。本发明生产的抗皱修护保湿精华具有良好的抗衰去皱能力，并且具有良好的皮肤屏障修护能力，具有蓝光、抗污染、减少皮肤损伤的能力，具有细胞级的UV防护作用，减缓细胞老化，并具有长效的皮肤水合能力。
Description
技术领域
本发明涉及化妆品领域，特别是指一种依克多因抗皱修护保湿精华及制备方法。
背景技术
传统的抗皱产品往往是用高分子成膜剂紧致提拉以达到淡化细纹，或者是填充以隐盖皱纹，这类产品无法真正达到抗皱效果，还有一类以补充蛋白等营养物质的产品，皮肤真正吸收到的很少，所以效果也一般。
发明内容
本发明提供了一种依克多因抗皱修护保湿精华及制备方法以解决背景技术中提到的问题。
为解决上述技术问题，本发明的实施例提供如下方案：
一种依克多因抗皱修护保湿精华，包括以下质量百分比组分：
水77.3％；
甘油5％；
1,3-丙二醇5％；
多肽组合物5％；
极大螺旋藻提取物2％；
1,2-戊二醇2％；
滋养组合物2％；
抑菌组合物0.6％；
保湿组合物0.5％；
糖原0.2％；
尿囊素0.2％；
卡波姆0.15％；
三乙醇胺0.15％；
EDTA二钠0.05％。
较佳的，所述多肽组合物包括：C精氨酸/赖氨酸多肽、乙酰基六肽-8、棕榈酰三肽-5、棕榈酰四肽-7、棕榈酰五肽-4、二肽二氨基丁酰苄基酰胺二乙酸盐、十三肽-1、肌肽、水、甘油、1,2-己二醇。
较佳的，所述滋养组合物包括透明质酸钠交联聚合物、透明质酸钠、乙酰化透明质酸钠、水解透明质酸钠、1,2-戊二醇、乙基己基甘油和水。
较佳的，所述滋养组合物还包括依克多因。
较佳的，所述抑菌组合物包括辛酰羟肟酸和丙二醇。
较佳的，所述保湿组合物包括水、丁二醇和白薇提取物。
本发明还公开了一种依克多因抗皱修护保湿精华的制备方法，包括以下步骤：
S1、准备原料，准备组分A、组分B和组分C，其中组分A包括水、甘油、1,3-丙二醇、极大螺旋藻提取物、糖原、尿囊素、卡波姆和EDTA二钠，组分B包括1,2-戊二醇、抑菌组合物和三乙醇胺，组分C包括多肽组合物、滋养组合物、保湿组合物；
S2、将组分A加热到80℃使之充分溶解，然后开始降温；
S3、降温至45℃，加入组分B，搅拌并继续降温；
S4、降温至40℃，加入预先溶解的组分C，充分混合均匀；
S5、冷却至室温出料。
S6、半成品检验、储存；
S7、灌装，包装、
S8、成品检验、入库。
较佳的，所述S6中半成品检验时，检验微生物是否达标，达标后采用密封储存的方式进行存储。
较佳的，所述S7中进行灌装包装时，采用真空灌装机进行灌装。
本发明的上述方案至少包括以下有益效果：
本发明生产的抗皱修护保湿精华具有良好的抗衰去皱能力，并且具有良好的皮肤屏障修护能力，具有蓝光、抗污染、减少皮肤损伤的能力，具有细胞级的UV防护作用，减缓细胞老化，并具有长效的皮肤水合能力。
具体实施方式
下面将更详细地描述本公开的示例性实施例。虽然下述中显示了本公开的示例性实施例，然而应当理解，可以以各种形式实现本公开而不应被这里阐述的实施例所限制。相反，提供这些实施例是为了能够更透彻地理解本公开，并且能够将本公开的范围完整的传达给本领域的技术人员。
实施例1
本实施例提供了一种依克多因抗皱修护保湿精华，包括以下质量百分比组分：
水77.3％；
甘油5％；
1,3-丙二醇5％；
多肽组合物5％；
极大螺旋藻提取物2％；
1,2-戊二醇2％；
滋养组合物2％；
抑菌组合物0.6％；
保湿组合物0.5％；
糖原0.2％；
尿囊素0.2％；
卡波姆0.15％；
三乙醇胺0.15％；
EDTA二钠0.05％。
其中，所述多肽组合物包括：C精氨酸/赖氨酸多肽、乙酰基六肽-8、棕榈酰三肽-5、棕榈酰四肽-7、棕榈酰五肽-4、二肽二氨基丁酰苄基酰胺二乙酸盐、十三肽-1、肌肽、水、甘油、1,2-己二醇，各成分的质量相同。
其中，所述滋养组合物包括透明质酸钠交联聚合物、透明质酸钠、乙酰化透明质酸钠、水解透明质酸钠、1,2-戊二醇、乙基己基甘油和水，各成分的质量相同。
其中，所述滋养组合物还包括依克多因。
其中，所述抑菌组合物包括辛酰羟肟酸和丙二醇，辛酰羟肟酸和丙二醇的质量比为1:2。
其中，所述保湿组合物包括水、丁二醇和白薇提取物，水、丁二醇和白薇提取物的质量比为2:1:1。
其中，本发明生产的抗皱修护保湿精华具有良好的抗衰去皱能力，并且具有良好的皮肤屏障修护能力，具有蓝光、抗污染、减少皮肤损伤的能力，具有细胞级的UV防护作用，减缓细胞老化，并具有长效的皮肤水合能力。
实施例2
本实施例提供了一种依克多因抗皱修护保湿精华，包括以下质量百分比组分：
水77.3％；
甘油5％；
1,3-丙二醇5％；
多肽组合物5％；
极大螺旋藻提取物2％；
1,2-戊二醇2％；
滋养组合物2％；
抑菌组合物0.6％；
保湿组合物0.5％；
糖原0.2％；
尿囊素0.2％；
卡波姆0.15％；
三乙醇胺0.15％；
EDTA二钠0.05％。
其中，所述多肽组合物包括：C精氨酸/赖氨酸多肽、乙酰基六肽-8、棕榈酰三肽-5、棕榈酰四肽-7、棕榈酰五肽-4、二肽二氨基丁酰苄基酰胺二乙酸盐、十三肽-1、肌肽、水、甘油、1,2-己二醇，各成分的质量相同。
其中，所述滋养组合物包括透明质酸钠交联聚合物、透明质酸钠、乙酰化透明质酸钠、水解透明质酸钠、1,2-戊二醇、乙基己基甘油和水，各成分的质量相同。
其中，所述滋养组合物还包括依克多因。
其中，所述抑菌组合物包括辛酰羟肟酸和丙二醇，辛酰羟肟酸和丙二醇的质量比为1:3。
其中，所述保湿组合物包括水、丁二醇和白薇提取物，水、丁二醇和白薇提取物的质量比为2:1:2。
其中，本发明生产的抗皱修护保湿精华具有良好的抗衰去皱能力，并且具有良好的皮肤屏障修护能力，具有蓝光、抗污染、减少皮肤损伤的能力，具有细胞级的UV防护作用，减缓细胞老化，并具有长效的皮肤水合能力。
实施例3
本实施例还公开了一种依克多因抗皱修护保湿精华的制备方法，包括以下步骤：
S1、准备原料，准备组分A、组分B和组分C，其中组分A包括水、甘油、1,3-丙二醇、极大螺旋藻提取物、糖原、尿囊素、卡波姆和EDTA二钠，组分B包括1,2-戊二醇、抑菌组合物和三乙醇胺，组分C包括多肽组合物、滋养组合物、保湿组合物；
S2、将组分A加热到80℃使之充分溶解，然后开始降温；
S3、降温至45℃，加入组分B，搅拌并继续降温；
S4、降温至40℃，加入预先溶解的组分C，充分混合均匀；
S5、冷却至室温出料。
S6、半成品检验、储存；
S7、灌装，包装、
S8、成品检验、入库。
其中，所述S6中半成品检验时，检验微生物是否达标，达标后采用密封储存的方式进行存储。
其中，所述S7中进行灌装包装时，采用真空灌装机进行灌装。
本工艺流程简单，操作方便，适合工业生产。
以上所述是本发明的优选实施方式，应当指出，对于本技术领域的普通技术人员来说，在不脱离本发明所述原理的前提下，还可以作出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。
Claims (9)
1.一种依克多因抗皱修护保湿精华，其特征在于，包括以下质量百分比组分：
水77.3％；
甘油5％；
1,3-丙二醇5％；
多肽组合物5％；
极大螺旋藻提取物2％；
1,2-戊二醇2％；
滋养组合物2％；
抑菌组合物0.6％；
保湿组合物0.5％；
糖原0.2％；
尿囊素0.2％；
卡波姆0.15％；
三乙醇胺0.15％；
EDTA二钠0.05％。
2.根据权利要求1所述的一种依克多因抗皱修护保湿精华，其特征在于，所述多肽组合物包括：C精氨酸/赖氨酸多肽、乙酰基六肽-8、棕榈酰三肽-5、棕榈酰四肽-7、棕榈酰五肽-4、二肽二氨基丁酰苄基酰胺二乙酸盐、十三肽-1、肌肽、水、甘油、1,2-己二醇。
3.根据权利要求1所述的一种依克多因抗皱修护保湿精华，其特征在于，所述滋养组合物包括透明质酸钠交联聚合物、透明质酸钠、乙酰化透明质酸钠、水解透明质酸钠、1,2-戊二醇、乙基己基甘油和水。
4.根据权利要求3所述的一种依克多因抗皱修护保湿精华，其特征在于，所述滋养组合物还包括依克多因。
5.根据权利要求1所述的一种依克多因抗皱修护保湿精华，其特征在于，所述抑菌组合物包括辛酰羟肟酸和丙二醇。
6.根据权利要求1所述的一种依克多因抗皱修护保湿精华及制备方法，其特征在于，所述保湿组合物包括水、丁二醇和白薇提取物。
7.一种依克多因抗皱修护保湿精华的制备方法，其特征在于，包括以下步骤：
S1、准备原料，准备组分A、组分B和组分C，其中组分A包括水、甘油、1,3-丙二醇、极大螺旋藻提取物、糖原、尿囊素、卡波姆和EDTA二钠，组分B包括1,2-戊二醇、抑菌组合物和三乙醇胺，组分C包括多肽组合物、滋养组合物、保湿组合物；
S2、将组分A加热到80℃使之充分溶解，然后开始降温；
S3、降温至45℃，加入组分B，搅拌并继续降温；
S4、降温至40℃，加入预先溶解的组分C，充分混合均匀；
S5、冷却至室温出料。
S6、半成品检验、储存；
S7、灌装，包装、
S8、成品检验、入库。
8.根据权利要求7所述的一种依克多因抗皱修护保湿精华的制备方法，其特征在于，所述S6中半成品检验时，检验微生物是否达标，达标后采用密封储存的方式进行存储。
9.根据权利要求7所述的一种依克多因抗皱修护保湿精华的制备方法，其特征在于，所述S7中进行灌装包装时，采用真空灌装机进行灌装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210219964.XA CN114533646A (zh) | 2022-03-08 | 2022-03-08 | 一种依克多因抗皱修护保湿精华及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210219964.XA CN114533646A (zh) | 2022-03-08 | 2022-03-08 | 一种依克多因抗皱修护保湿精华及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114533646A true CN114533646A (zh) | 2022-05-27 |
Family
ID=81663954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210219964.XA Pending CN114533646A (zh) | 2022-03-08 | 2022-03-08 | 一种依克多因抗皱修护保湿精华及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114533646A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115607475A (zh) * | 2022-09-15 | 2023-01-17 | 广州市小谭科技有限公司 | 一种抗衰去皱复合多肽组合物及其应用 |
| CN116370347A (zh) * | 2023-03-31 | 2023-07-04 | 华熙生物科技股份有限公司 | 抗炎组合物及其用途 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109464342A (zh) * | 2018-12-29 | 2019-03-15 | 广州市盛美化妆品有限公司 | 一种抗衰老精华液及其制备方法 |
| CN109984952A (zh) * | 2017-12-29 | 2019-07-09 | 广州佳洁化妆品有限公司 | 一种含多种小分子肽类复配祛皱抗衰的精华液及制备方法 |
| CN109998953A (zh) * | 2019-04-09 | 2019-07-12 | 上海肠寿果生物科技有限公司 | 一种用于改善肤质的多肽精华液 |
| CN110585052A (zh) * | 2019-10-15 | 2019-12-20 | 上海龙禧投资有限公司 | 一种眼周皮肤抗皱用组合物 |
-
2022
- 2022-03-08 CN CN202210219964.XA patent/CN114533646A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109984952A (zh) * | 2017-12-29 | 2019-07-09 | 广州佳洁化妆品有限公司 | 一种含多种小分子肽类复配祛皱抗衰的精华液及制备方法 |
| CN109464342A (zh) * | 2018-12-29 | 2019-03-15 | 广州市盛美化妆品有限公司 | 一种抗衰老精华液及其制备方法 |
| CN109998953A (zh) * | 2019-04-09 | 2019-07-12 | 上海肠寿果生物科技有限公司 | 一种用于改善肤质的多肽精华液 |
| CN110585052A (zh) * | 2019-10-15 | 2019-12-20 | 上海龙禧投资有限公司 | 一种眼周皮肤抗皱用组合物 |
Non-Patent Citations (3)
| Title |
|---|
| 天津君美企业管理咨询有限公司: "EW补水修护面膜", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20210205152009XA5V8&NID=20210205152009XA5V8》 * |
| 广州合益美肌科技有限公司: "SpotlessAnswer乙酰基六肽原液", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20200804171128BWFQU&NID=20200804171128BWFQU》 * |
| 广州市赞美化妆品有限公司: "LΛHCFITE依克多因补水紧致面", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=202010281814353CJED&NID=202010281814353CJED》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115607475A (zh) * | 2022-09-15 | 2023-01-17 | 广州市小谭科技有限公司 | 一种抗衰去皱复合多肽组合物及其应用 |
| CN116370347A (zh) * | 2023-03-31 | 2023-07-04 | 华熙生物科技股份有限公司 | 抗炎组合物及其用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114533646A (zh) | 一种依克多因抗皱修护保湿精华及制备方法 | |
| CN102746493B (zh) | 一种全生物基聚丁二酸丁二醇酯的制备方法 | |
| CN104403088A (zh) | 一种改性聚醚胺环氧固化剂及其制备方法 | |
| CN110606941B (zh) | 一种低端羧基耐水解聚酯及其制备方法和用途 | |
| CN112675067A (zh) | 一种多肽紧颜修护精华素及其制备方法 | |
| CN115418085A (zh) | 一种生物可降解pbat/pla共混薄膜 | |
| CN101445592A (zh) | 可生物降解枝化共聚酯及其制备方法 | |
| CN112679709A (zh) | 一种热收缩膜用聚酯及其制备方法 | |
| CN108963024A (zh) | 一种高反射率的一体化光伏封装材料及应用 | |
| CN102718950B (zh) | 一种可生物降解聚丁二酸丁二醇酯的制备方法 | |
| CN102604347A (zh) | 一种壳聚糖改性聚乳酸材料的γ射线辐照制备方法 | |
| CN113549306A (zh) | 一种pbat树脂组合物及其制备方法 | |
| CN109867819A (zh) | 聚乳酸-淀粉-pva复合可降解包装膜及其制备方法 | |
| CN103804665B (zh) | 一种多羟基聚酯的制备方法 | |
| CN101967252B (zh) | 一种镁钙锌复合热稳定剂及其制备方法和用途 | |
| CN104031246A (zh) | 高分子量和色泽优异的全生物基聚（对苯二甲酸丁二醇-共-己二酸丁二醇）酯的制备方法 | |
| CN108610517A (zh) | 一种纳米纤维素增强半纤维素基复合膜的制备方法 | |
| CN102731752B (zh) | 一种全生物基聚丁二酸丁二醇酯的制备方法 | |
| CN111675932A (zh) | 纯流平的水性聚氨酯流平剂 | |
| CN108329648A (zh) | 一种abs耐候色母 | |
| CN109401151A (zh) | 高品质聚乙烯醇流延膜及其制备方法和应用 | |
| CN103102647A (zh) | 高热收缩率聚酯薄膜的制备方法 | |
| CN107955253A (zh) | 一种弹性缓冲塑料包装缠绕膜材料及其制备方法 | |
| CN110028775A (zh) | 一种抗拉伸打包带材料的制备方法 | |
| CN108641338A (zh) | 一种聚噻吩掺杂硬质导电薄膜及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220527 |
|
| RJ01 | Rejection of invention patent application after publication |